| News/In the News | About Us | Contact | Donate | Links |
Subject AreasHome
In the News News clips mentioning Essential Action's work. News Releases Biogenerics U.S. Congress is considering legislation that will create an FDA approval process for generic versions of biotech drugs. Drug Monopoly Enforcement Agenda Information on initiatives that seek to protect drug monopolies under the guise of fighting counterfeits, including the "Anti-Counterfeiting" Trade Agreement (ACTA). Pharmaceutical Industry Transparency Issues Essential Action campaign-related materials to promote transparency around Big Pharma's operations. Trade Agreements Bilateral and regional trade agreements are threatening to strip away the flexibilities that developing countries maintain under international trade rules. World Trade Organization A key concern is how generic drug manufacturers can achieve economies of scale under WTO rules. Country Disputes and Other Issues Seeking to lower medicines prices at the national level. Resolution Affirming the Doha Declaration The U.S. Congress is considering resolutions calling on the administration not to pressure countries using trade rule flexibilities to promote access to medicines, and supporting new mechanisms to promote R&D. Publications and Papers Links to a variety of published papers on which we have worked recently. Fact Sheets Easy-to-understand materials on key access-to-medicines issues. Home |
Secret Counterfeiting Treaty Public Must be Made Public, Global Organizations SayMonday, September 15. 2008
FOR IMMEDIATE RELEASE
September 15, 2008 For more information contact: USA: Robert Weissman, director, Essential Action +1 (202) 387-8030, (Mobile) +1 (202) 360-1844, rob@essential.org Australia: Kimberlee Weatherall, Lecturer, TC Beirne School of Law, The University of Queensland and Board Member, Australian Digital Alliance, (Mobile) +61 4 0376 2544, k.weatherall@law.uq.edu.au Canada: Michael Geist, Canada Research Chair in Internet and e-commerce Law, University of Ottawa, (Office) +1 (613) 562-5800 ext. 3319, mgeist@uottawa.ca Korea: Byoung-il Oh, Korean Progressive Network Jinbonet, (Tel) +82-2-774-455, (Mobile) +82-19-213-9199, antiropy@www.jinbo.net Secret Counterfeiting Treaty Public Must be Made Public, Global Organizations Say More than 100 public interest organizations from around the world today called on officials from the countries negotiating Anti-Counterfeiting Trade Agreement (ACTA) -- the United States, the European Union, Switzerland, Japan, South Korea, Canada, Mexico, Australia and New Zealand -- to publish immediately the draft text of the agreement. Secrecy around the treaty negotiation has fueled concerns that its terms will undermine vital consumer interests. Organizations signing the letter include: Consumers Union, Electronic Frontier Foundation, Essential Action, IP Justice, Knowledge Ecology International, Public Knowledge, Global Trade Watch, U.S. Public Interest Research Group, IP Left (Korea), Australian Digital Alliance, The Canadian Library Association, Consumers Union of Japan, National Consumer Council (UK) and Doctors without Borders’ Campaign for Essential Medicines. Based on leaked documents and industry comments on the proposed treaty, the groups expressed concerns that ACTA may: + Require Internet Service Providers to monitor all consumers' Internet communications; + Interfere with fair use of copyrighted materials; + Criminalize peer-to-peer electronic file sharing; and + Undermine access to low-cost generic medicines. "Because the text of the treaty and relevant discussion documents remain secret, the public has no way of assessing whether and to what extent these and related concerns are merited," say the public interest groups in their letter. Worsening the problem is the perception that industry lobbyists have access to the text and are influencing the negotiations. "The lack of transparency in negotiations of an agreement that will affect the fundamental rights of citizens of the world is fundamentally undemocratic. It is made worse by the public perception that lobbyists from the music, film, software, video games, luxury goods and pharmaceutical industries have had ready access to the ACTA text and pre-text discussion documents through long-standing communication channels." "Why in the world are trade negotiators keeping the treaty a secret?" asks Robert Weissman, director of Essential Action. "Are they worried about counterfeiters influencing the negotiations? What possible rationale is there for secrecy -- other than to lock out the public? Intentionally or not, a treaty to prevent unauthorized copying may easily go too far, and undermine important consumer interests. That's why it is so important that this deal be negotiated in the light of day." Essential Action is a public health and corporate accountability group located in Washington, DC. --- The list of signers and additional quotes from groups signing the letter is available on the continuatio of this post, or as downloadable rtf at: ACTA-signon.rtf ACTAquotes.rtf September 15, 2008
Dear Minister, Re: Anti-Counterfeiting Trade Agreement Negotiations We are writing to urge the negotiators of the Anti-Counterfeiting Trade Agreement (ACTA) to immediately publish the draft text of the agreement, as well as pre-draft discussion papers (especially for portions for which no draft text yet exists), before continuing further discussions over the treaty. We ask also that you publish the agenda for negotiating sessions and treaty-related meetings in advance of such meetings, and publish a list of participants in the negotiations. There is no legitimate rationale to keep the treaty text secret, and manifold reasons for immediate publication. The trade in products intended to deceive consumers as to who made them poses important but complicated public policy issues. An overbroad or poorly drafted international instrument on counterfeiting could have very harmful consequences. Based on news reports and published material from various business associations, we are deeply concerned about matters such as whether the treaty will: + Require Internet Service Providers to monitor all consumers' Internet communications, terminate their customers' Internet connections based on rights holders' repeat allegation of copyright infringement, and divulge the identity of alleged copyright infringers possibly without judicial process, threatening Internet users' due process and privacy rights; and potentially make ISPs liable for their end users' alleged infringing activity; + Interfere with fair use of copyrighted materials; + Criminalize peer-to-peer file sharing; + Interfere with legitimate parallel trade in goods, including the resale of brand-name pharmaceutical products; + Impose liability on manufacturers of active pharmaceutical ingredients (APIs), if those APIs are used to make counterfeits -- a liability system that may make API manufacturers reluctant to sell to legal generic drug makers, and thereby significantly damage the functioning of the legal generic pharmaceutical industry; + Improperly criminalize acts not done for commercial purpose and with no public health consequences; and + Improperly divert public resources into enforcement of private rights. Because the text of the treaty and relevant discussion documents remain secret, the public has no way of assessing whether and to what extent these and related concerns are merited. Equally, because the treaty text and relevant discussion documents remain secret, treaty negotiators are denied the insights and perspectives that public interest organizations and individuals could offer. Public review of the texts and a meaningful ability to comment would, among other benefits, help prevent unanticipated pernicious problems arising from the treaty. Such unforeseen outcomes are not unlikely, given the complexity of the issues involved. The lack of transparency in negotiations of an agreement that will affect the fundamental rights of citizens of the world is fundamentally undemocratic. It is made worse by the public perception that lobbyists from the music, film, software, video games, luxury goods and pharmaceutical industries have had ready access to the ACTA text and pre-text discussion documents through long-standing communication channels. The G8's recent Declaration on the World Economy implored negotiators to conclude ACTA negotiations this year. The speed of the negotiations makes it imperative that relevant text and documents be made available to the citizens of the world immediately. We look forward to your response, and to working with you toward resolution of our concerns. Sincerely, Essential Action c/o Robert Weissman, Director P.O. Box 19405 Washington, DC, USA 20036 Tel +1 (202) 387-8030 Fax +1 (202) 234-5176 Act Up East Bay Oakland, CA, USA Act Up Paris Paris, France African Underprivileged Children's Foundation (AUCF) Lagos, Nigeria AIDS Access Foundation Thailand AIDS Healthcare Foundation Los Angeles, CA, USA AIDS Treatment News Philadelphia, PA, USA American Medical Student Association Reston, VA, USA AIS Colombia Bogotá, Colombia ASEED Europe Amsterdam, The Netherlands Asia Pacific Network of People Living with HIV/AIDS (APN+) Australian Digital Alliance Kingston, Australia Australian National University Canberra, Australia Australian Privacy Foundation Sydney, Australia Bharatiya Krishakn Samaj New Delhi, India BUKO Pharma-Kampagne Bielefeld, Germany The Canadian HIV/AIDS Legal Network Toronto, Canada The Canadian Internet Policy & Public Interest Clinic (CIPPIC) University of Ottawa, Faculty of Law Ottawa, Canada The Canadian Library Association Ottawa, Canada The Canadian Treatment Action Council Toronto, Canada Center for Democracy and Technology Washington, DC, USA Center for Digital Democracy Washington, DC, USA Center for Policy Analysis on Trade and Health (CPATH) San Francisco, CA, USA Centre for Safety & Rational Use of Indian Systems of Medicine Ibn Sina Academy of Medieval Medicine & Sciences Aligarh, India The Center for Women's Culture & Theory Korea Chinese Domain Name User Alliance Beijing, China Christian Media Network Korea CHOICE (Australian Consumers Association) Marrickville, Australia Community HIV/AIDS Mobilization Project (CHAMP) New York, NY, USA Congress of South African Trade Unions (COSATU) Cape Town, South Africa Consumentenbond The Hague, Netherlands Consumer Action San Francisco, CA, USA Consumer Federation of America Washington, DC, USA Consumers Union (Publisher of Consumer Reports) Yonkers, NY, USA Consumers Union of Japan (Nihon Shohisha Renmei) Tokyo, Japan La Corporacion Opcion por el Derecho a Ser y el Deber de Hacer, NIT Bogotá, Colombia Corporate Europe Observatory Amsterdam, The Netherlands Cultural Action Korea Diverse Women for Diversity (DWD) New Delhi, India Drug Study Group (DSG) Thailand Ecologist Collective (Colectivo ecologista Jalisco A.C.) Guadalajara, México Egyptian Initiative for Personal Rights Cairo, Egypt Electronic Frontier Foundation San Francisco, CA, USA Electronic Frontiers Australia Adelaide, Australia The Electronic Privacy Information Center (EPIC) Washington, DC, USA European AIDS Treatment Group (EATG) Brussels, Belgium Foreign Policy in Focus Institute for Policy Studies Washington, DC, USA Foundation for Integrative AIDS Research (FIAR) Brooklyn, NY, USA Fundación Ifarma Bogotá, Colombia Foundation For Consumers (FFC) Thailand Foundation for Media Alternatives Philippines Foundation for Research in Science Technology & Ecology (RFSTE) India Free Press Washington, DC, USA FTA Watch Thailand Global AIDS Alliance, Washington, DC, USA Global Health through Education, Training & Service (GHETS) Attleborough, MA, USA Global Trade Watch Washington, DC, USA Gram Bharati Samiti Society for Rural Development Amber, India Gyeonggi NGO Network Korea Health Action International (HAI) – Africa Nairobi, Kenya Health Action International (HAI) – Asia Pacific Colombo, Sri Lanka Health Action International (HAI) – Europe Amsterdam, The Netherlands Health Action International (HAI) – Global Amsterdam, The Netherlands Health Action International – Latin America & Caribbean Lima, Perú Health GAP (Global Access Project) Philadelphia, PA, USA HealthWrights (Workgroup for Peoples Health and Rights) Palo Alto, CA, USA Healthy Skepticism Inc. Adelaide, Australia Home Recording Rights Coalition Washington, DC, USA INEGroup Atlanta, GA, USA Information & Culture Nuri for the Disabled Korea Initiative For Health Equity & Society (IHES) New Delhi, India International Federation of Library Associations and Institutions (IFLA) The Hague, Netherlands International Peoples Health Council (South Asia) Intersect Worldwide India, South Africa and USA IP Justice San Francisco, CA, USA IPLeft Seoul, Korea Knowledge Ecology International (KEI) Geneva, Switzerland, London, UK and Washington, DC, USA Korean Progressive Network Jinbonet Seoul, Korea Labour, Health and Human Rights Development Centre Lagos, Nigeria Lawyers Collective HIV/AIDS Unit India Medsin-UK Médecins sans Frontières (Doctors without Borders) Campaign for Essential Medicines Geneva, Switzerland Media Access Project Washington, DC, USA La Mesa de ONGs Con Trabajo en VIH/SIDA Bogotá, Colombia Misión Salud Bogotá, Colombia National Consumer Council (NCC) London, UK National Working Group on Patent Laws New Delhi, India Navdanya New Delhi, India Netzwerk Freies Wissen Berlin, Germany Open Rights Group UK Paradise Hospital Port Moresby, Papau New Guinea People's Coalition for Media Reform Seoul, Korea Phasuma Consultancy & Training Amsterdam, The Netherlands Positive Malaysian Treatment Access & Advocacy Group (MTAAG+). Malaysia Privacy Activism USA Privacy Rights Clearinghouse San Diego, CA, USA Public Knowledge Washington, DC, USA Rural Reconstruction Nepal (RRN) Kathmandu, Nepal Social movement to combat private media ownership and enhance public media Korea Student Global AIDS Campaign USA Swisslinux.org Mayens-de-Chamoson, Switzerland The Transparency and Accountability Network New York, NY, USA Third World Network Malaysia Universities Allied for Essential Medicines (UAEM) UK, USA U.S. Public Interest Research Group (PIRG) Washington, DC, USA Women & Health ! (WAH ! ) India **Individuals** Jamie Acosta, PhD, LCSW, CHES Miami, FL, USA Mr. Jose L. Aguilar Justice and Peace Commission Mexico City, Mexico Beate Amler Trade Union Researcher Berlin, Germany Professor Brook K. Baker Northeastern University School of Law Program on Human Rights and the Global Economy Boston, MA, USA Gladys Baldew Public Health Consultant Netherlands Laurel Baldwin-Ragaven, MD Asylum Hill Family Practice Center Hartford, CT, USA Murtala Bello Pharmacist, Ministry of Health Sokoto, Nigeria Jennifer Bruenger Reference Librarian & Education Program Coordinator Linda Hall Library of Science, Engineering & Technology Mission, KS, USA Erin Burns Former National Organizer, Student Global AIDS Campaign (SGAC) Jacksonville, FL, USA Sylvia Caras, PhD Santa Cruz, CA, USA Ramon Certeza Director for Education, Research and Industrial Relations Confederation of Labor and Allied Social Services (CLASS) Manila, Philippines Sae-Rom Chae University of Illinois at Chicago College of Medicine Chicago, IL, USA Jeff Chester Executive Director Center for Digital Democracy Washington, DC, USA Don Christie President New Zealand Open Source Society Mark R. Costa Clay, NY, USA Chris Curry MD/PhD Candidate Loyola University Chicago Forest Park, IL, USA Dr Gopal Dabade President, Drug Action Forum - Karnataka Dharwad, India Anke Dahrendorf, LLM Junior Researcher, International and European Law University of Maastricht, The Netherlands Daniel de Beer, PhD Lecturer in Law Université Saint Louis Brussels, Belgium Dr. Gilles de Wildt Jiggins Lane Medical Centre Birmingham, UK John Dillon Program Coordinator KAIROS: Canadian Ecumenical Justice Initiatives Toronto, Canada Dr. David Egilman, MD, MPH Clinical Associate Professor Brown University Attleboro, MA, USA Professor Peter Evans Department of Sociology University of California, Berkeley, USA Thomas Alured Faunce Assoc. Professor, College of Law Assoc. Professor, Medical School, College of Medicine and Health Sciences Australian National University Canberra, Australia Professor Brian Fitzgerald Professor of Intellectual Property and Innovation Law Faculty Queensland University of Technology Brisbane, Australia Professor Sean Flynn Associate Director Program on Information Justice and Intellectual Property American University Washington College of Law Washington DC, USA Maurice J. Freedman Past President, American Library Association Mount Kisco, NY, USA Michael Geist Canada Research Chair in Internet and e-commerce Law University of Ottawa, Canada Jonathan Walter Giehl Ocala, Florida, USA Johnny Jesus Guaylupo PLWHA Brooklyn, NY, USA Dr. Chandra M. Gulhati Editor, Monthly Index of Medical Specialities (MIMS) New Delhi, India Mark W. Heffington, MD Cashiers, NC, USA Matthew Herder Visiting Professor of Law Loyola University Chicago Chicago, IL, USA Maggie Huff-Rousselle Chair, Pharmaceuticals Interest Working Group American Public Health Association Boston, MA, USA Doug Ireland, Journalist New York, NY, USA Professor S. Jayasundar, PhD Pharmacology Chennai, India Dr. K.R. John Dept. of Community Health Christian Medical College Vellore, India Puja Kapai Assistant Professor Faculty of Law The University of Hong Kong Alison Katz People’s Health Movement and Centre Europe Tiers Monde Geneva, Switzerland Niyada Kiatying-Angsulee, Ph.D. Chair, Social Pharmacy Research Unit (SPR) Faculty of Pharmaceutical Sciences Chulalongkorn University Bangkok, Thailand Professor Heinz Klug University of Wisconsin Law School Madison, WI, USA Senior Honorary Research Associate, University of the Witwatersrand Johannesburg, South Africa Adam M. Kost University of Illinois at Chicago College of Medicine Chicago, IL, USA Professor Joel Lexchin, MD York University Toronto, Canada Jiraporn Limpananont, PhD Social Pharmacy Research Unit Faculty of Pharmaceutical Sciences Chulalongkorn University Bangkok, Thailand Nicholas J. Lusiani International Network for Economic, Social and Cultural Rights ESCR-Net / Red-DESC / Réseau-DESC New York, NY, USA Hamish MacEwan Open ICT Consultant Wellington, New Zealand Dr. Duncan Matthews Reader in Intellectual Property Law School of Law Queen Mary, University of London United Kingdom Eduardo Mayorga ALAFAR (Ecuadorian Generic Pharmaceutical Association) Quito, Ecuador Dr. Jeni McAughey Whitehead, Northern Ireland Prof. David Menkes Waikato Clinical School University of Auckland Hamilton, New Zealand Mr. T. Mikindo, B.Pharms, MSc Pharmacist Ifakara Health Institute Dar Es Salaam, Tanzania Adrienne Mishkin Tulane University School of Medicine and School of Public Health and Tropical Medicine MD/MPH candidate, Class of 2009 New Orleans, LA, USA Isameldin M.A. Mustafa, B.Pharm The Director of Pharmaceutical Services Department National Health Insurance Fund Khartoum, Sudan Ibraheem Naeem Medical student Lahore, Pakistan Dr. Pat Neuwelt Public Health Physician and Professor Mt. Albert, Auckland, New Zealand Ahti Otala Espoo, Finland Frank Ottey Media, PA, USA Kevin Outterson Associate Professor of Law & Director of the Health Law Program Boston University School of Law Boston, MA, USA Dr. Carol Parlow Oakville, Canada Dr. Peter Parry Consultant Child & Adolescent Psychiatrist Senior Lecturer, Flinders University Oaklands Pk, Australia Ngufor Forkum Polycarp, BA, MEd, MA, DEA, Dip-ENSP, LLM Human Rights Training Unit Police Training School Yaounde, Cameroon Joana Ramos, MSW Cancer Resources & Advocacy Seattle, WA, USA Nicolas Rasmussen, MPhil, PhD, MPH Associate Professor National Drug and Alcohol Research Centre University of New South Wales Sydney, Australia Dr. Amitrajit Saha New Delhi, India A. Sankar Executive Director EMPOWER Tuticorin, India Dr. Canan Sargin, MD UNICEF Ankara, Turkey Dr. Gordon Schiff Associate Director, Center for Patient Safety Research and Practice Division of General Internal Medicine, Brigham and Women's Hospital Boston, MA, USA Claudio Schuftan, MD People’s Health Movement Vietnam Professor Susan K. Sell George Washington University Washington, DC USA Melissa Serrano Researcher University of the Phillippines Manila, Philippines Aaron Shaw Berkman Center for Internet and Society Harvard University Cambridge, Massachusetts, USA Dr. Mira Shiva, MD Coordinator, Initiative for Health, Equity and Society Founding Member, People's Health Movement New Delhi, India Dr. Vandana Shiva Navdanya New Delhi, India Beverley Snell Essential Medicines and Community Health Specialist Centre for International Health Macfarlane Burnet Institute for Medical Research and Public Health Melbourne, Australia Wilma Teran Pharmaceutical Biochemist, Public Health Platform on Access to Medicines and Intellectual Property La Paz, Bolivia Clinton Henry Trout, MPH Candidate for Doctor of Public Health Boston University Boston, MA, USA Karolina Tuomisto Medical Student Helsinki, Finland Mike Waghorne Retired Former Assistant General Secretary Public Services International Esquibien, France Richard Walther Alexandria, Virginia, USA Professor Kimberlee Weatherall TC Beirne School of Law The University of Queensland Brisbane, Australia Patricia Whelehan, PhD Professor, Anthropology State University of New York-Potsdam Potsdam, NY, USA Edlira Xhafa Researcher Education International Nyon, Switzerland Julie M. Zito, PhD Professor, Pharmacoepidemiology University of Maryland, Baltimore Baltimore, MD, USA ------------- OPENNESS IN TRADE AND OTHER MULTILATERAL NEGOTIATIONS Negotiating texts are commonly made public in multilateral trade negotiation, although some trade negotiations are characterized by secrecy. Examples of negotiations where texts are or were made public include: The current Doha Round negotiations at the World Trade Organization; http://www.wto.org/english/tratop_e/dda_e/dda_e.htm The Free Trade Area of the Americas; http://www.ftaa-alca.org/FTAADraft03/Index_e.asp The Multilateral Agreement on Investment (although initial texts were not made public) http://www.oecd.org/document/35/0,3343,en_2649_33783766_1894819_1_1_1_1,00.html Draft text at the World Health Organization, where resolutions are published in advance of consideration and treaty or treaty-like negotiations are handled openly, including this example of follow-on negotiations for the Framework Convention on Tobacco Control: http://www.who.int/gb/fctc/ The World Intellectual Property Organization, including this example of a draft Treaty on the Protection of Broadcasting Organizations: http://www.wipo.int/meetings/en/doc_details.jsp?doc_id=57213 ------- COMMENTS ON SECRECY SURROUNDING ACTA: Kimberlee Weatherall, Lecturer, TC Beirne School of Law, The University of Queensland, and Board Member, Australian Digital Alliance "It's extraordinary that a treaty which potentially affects such a wide range of interests would be negotiated behind closed doors: there's too much at stake. Secrecy is only increasing people's fears, and the belief that the negotiations aren't taking sufficient account of the public interest." Professor David Fewer, Canadian Internet Policy & Public Interest Clinic (CIPPIC), University of Ottawa, Faculty of Law "We're looking for the Canadian government to show leadership in introducing transparency and responsible consumer consultation to ACTA discussions." Professor Michael Geist, Canada Research Chair in Internet and e-commerce Law, University of Ottawa, Faculty of Law “ACTA has raised concerns for millions of citizens around the world. The time has come to lift the veil of secrecy and ensure that the future negotiations occur in an open and transparent environment.” Heeseob Nam, IP Left, Seoul, Korea "ACTA is another name for "kicking away the ladder" with which the industrialised nations climbed to the top. During the debate of Patent Act of 1790, Richard Wells argued that Americans should not be deprived of the advantage of imitating any of the English invention. This argument prevailed in the U.S. House, and the importation of patents became prohibited. This policy objective was invigorated by discrimination against foreign inventors in the US, and the statute lasted for about 70 years after 1793." Gwen Hinze, International Policy Director, Electronic Frontier Foundation, San Francisco, CA, USA "Despite its potentially harmful impact on consumers' privacy and free expression, and on Internet innovation, the citizens that stand to be directly affected by ACTA's provisions have been given almost no information about its contents. A leaked document includes new legal regimes to "encourage ISPs to cooperate with right holders", criminal measures, and increased border search powers, all of which raise considerable concern for citizens' civil liberties. Given the expedited timeframe in which it is being negotiated, citizens deserve to see the full text of ACTA now, so that they can evaluate its impact on their lives." James Love, Director, Knowledge Ecology International (KEI), Washington, DC, USA "Counterfeiting, properly defined, is a serious problem. Why the top secret negotiating approach for this treaty? The USTR won't even give us the agendas of the meetings or the names of the negotiators, or the proposed texts -- stuff that is normally transparent. I think the answer is the bogus use of an emotive term, counterfeiting, to push an unbalanced IP enforcement agenda, without any attention to civil or consumer rights. Unfortunately, there is bipartisan support for this assault on openness and transparency. Little wonder most people don't trust governments these days. Why should they?" Sherwin Siy, Staff Attorney and Director of Global Knowledge Initiative, Public Knowledge, Washington, DC, USA “It's incredible that such a significant document on such vital issues can move forward when virtually nothing is known or shared about its actual contents. If we are going to have international agreements on matters so essential to the exchange of speech, information, and knowledge, these agreements cannot be made in secret.”
Posted by Robert Weissman
in Drug Monopoly Enforcement Agenda, News Releases, Trade Agreements
at
09:47
Trackbacks
Trackback specific URI for this entry
No Trackbacks
Comments
Display comments as
(Linear | Threaded)
No comments
The author does not allow comments to this entry
Competition entry by David Cummins powered by Serendipity v1.0 |
ACCESS TO MEDICINES BULLETINEssential Action's free Global Access to Medicines e-Bulletin aims to be a reliable and easy-to-use resource for those who
want to keep up to date on key issues and the latest developments related to access to medicines in the developing world. Subscribe here. To view all Global Access to Medicines e-Bulletins click here. Contact InformationEssential Action's Access to Medicines Project
P.O. Box 19405 Washington, D.C. 20036 USA tel: 1-202-387-8030 fax: 1-202-234-5176 E-mail: Robert Weissman, Director rob@essential.org Jim Donahue, Attorney Focus: Pharmaceutical Industry Transparency jdonahue@essential.org Peter Maybarduk, Attorney Focus: Technical Assistance for IP-medicines issues; Counterfeit Drugs peter.maybarduk@essentialinformation.org Sarah Rimmington, Attorney Focus: Advocacy & Communications; Biogenerics; IMF & Health srimmington@essentialinformation.org About UsEssential Action's Access to Medicines Project is working to overcome patent and other intellectual property barriers to affordable medicines. Read more About Us
|